Fibroblast Growth Factor 21 Ameliorates Endothelin I-Induced Hypertension Partly Through PPAR γ Pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fibroblast Growth Factor 21 Ameliorates Endothelin I-Induced Hypertension Partly Through PPAR γ Pathway

Published:2022-05-24 Issue:4 Volume:28 Page:
ISSN:1573-3904
Container-title:International Journal of Peptide Research and Therapeutics
language:en
Short-container-title:Int J Pept Res Ther

Author:

Li Shuai,Li Shanshan,Zhang Weiwei,Ma Tianyi,Wang Nan,Sun Tianguo,Li Tie,Shao Shuli,Li Deshan

Funder

Heilongjiang Province Fundamental Research Funds

Heilongjiang Provincial Universities

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Molecular Medicine,Biochemistry,Bioengineering,Analytical Chemistry

Link

https://link.springer.com/content/pdf/10.1007/s10989-022-10408-y.pdf

Reference36 articles.

1. Acuna L, Sanchez P, Soler L, Alvis LF (2015) Total cholesterol (Tc), low-density lipoprotein cholesterol (Ldl-C) and high-density lipoprotein cholesterol (Hdl-C) levels in patients with hypertension (Ht), Diabetes (Dm), both (Ht And Dm) and chronic kidney disease (Ckd). Value Health 18(7):A405–A406

2. Alexei K, Tatiyana LS, Anja K, Amy MF, Radmila M, Elizabeth JG, George ES, Lisa JH, Julie SM, Rebecca AO, Jesper G, Joseph TB, Eric DH, Victor JW, Dehan L, Farrokh MS, Richard J, Armen BS (2005) FGF-21 as a novel metabolic regulator. JCI 115:1627–1635

3. Andrew CA, Christine CC, Tamer C, Alexei K (2012) FGF21 requires βklotho to act in vivo. PLoS ONE 7(11):e49977

4. Bart S, Wolfgang K, Aïda H, Régine M, Marilyne L, Inés PT, Philippe D, Abdessamad F, Giulia C, Jean CF, Jamila N, Jacques M, Alain T (1998) Activation of human aortic smooth-muscle cells is inhibited by PPAR-α but not by PPAR-γ activators. Nature 393:790–793

5. Bernard Z, Christoph W, John ML, David F, Erich B, Stefan H, Michaela M, Theresa D, Odd EJ, Hans JW, Uli CB, Silvio EI (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117–2128

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3